Juàn Fueyo

The University of Texas MD Anderson Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

54h-index22.6kcitations519works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(336), CAR-T cell therapy research(190), Cancer Research and Treatments(176), RNA Interference and Gene Delivery(76), Glioma Diagnosis and Treatment(47)

Publications512 total

EXTH-106. Oncolytic adenovirus armed with immune stimulators: a promising partner for CAR T cell therapy in primary and metastatic malignant brain tumors
Neuro-Oncology·2025Open Access
EXTH-33. The oncolytic adenovirus RGDOX sensitizes the anti-tumor efficacy of immune checkpoint blockades in murine melanoma brain metastases models
Neuro-Oncology·2025Open Access
CTNI-47. PHASE I TRIAL OF SINGLE INTRATUMORAL INJECTION OF DNX-2440 ONCOLYTIC ADENOVIRUS IN RECURRENT GLIOBLASTOMA PATIENTS
Neuro-Oncology·2025Open Access
TIP-21. Phase I trial of mesenchymal stem cells carrying Delta-24-RGD given intraarterially in recurrent glioma: Early report
Neuro-Oncology·2025Open Access
TMIC-58. A New View of Microvascular Proliferation: PDGFRB+ Perivascular Stromal Cells Drive MVP Formation, Immunosuppression and Stemness in Glioblastoma
Neuro-Oncology·2025
308 Arming oncolytic adenoviruses with immune stimulators: enhancing CAR T cell therapy for malignant primary and metastatic brain tumors
Regular and Young Investigator Award Abstracts·2025Open Access
TMIC-53. Novel therapy for diffuse midline glioma: Targeting oncohistone drivers with P300/CBP inhibition and Delta-24-RGD
Neuro-Oncology·2025Open Access
IMMU-48. Ruxolitinib enhances viroimmunotherapy of gliomas: targeting JAK-guided immunosuppressive pathways
Neuro-Oncology·2025Open Access
EXTH-19. The oncolytic adenovirus Delta-24-RGD achieves antitumor polarization of the chordoma tumor microenvironment in human and murine models of chordoma
Neuro-Oncology·2025Open Access
IMMU-63. Uncovering alternative innate immunity pathways in glioma viroimmunotherapy
Neuro-Oncology·2025Open Access
IMMU-39. T cell receptor diversity is a predictor of therapy response in patients with gliomas treated with Delta-24-RGD
Neuro-Oncology·2025
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
UNC Libraries·2025Open Access
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
UNC Libraries·2025Open Access
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nature Medicine·2025· 1 citedOpen Access
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas
Cell Reports Medicine·2025· 3 citedOpen Access
Virus Against Cancer: Paradigm-Shifting Biological Concepts
Current Neurology and Neuroscience Reports·2025· 1 cited
Effect of armed oncolytic adenovirus on immunotherapy for primary and metastatic brain tumors.
Journal of Clinical Oncology·2025
Retraction Note: Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences
Oncogene·2025Open Access
The multilayered control of acetylation during adenovirus-based immunotherapy of cancer
Molecular Therapy Oncology·2025· 1 citedOpen Access
1341 Oncolytic Adenoviral Infection and Subsequent Immunogenic Cell Death Achieves Intracranial Tumor Control in Disparate Models of Melanoma Brain Metastases
Neurosurgery·2025
page 1 of 26Next →

Frequent Co-authors

Candelaria Gomez‐Manzano(40), Marta M. Alonso(18), Frederick F. Lang(17), Hong Jiang(15), Ramón Alemany(11), Athanassios P. Kyritsis(8), Charles A. Conrad(7), Kenneth Aldape(7), Victor A. Levin(6), W. K. Alfred Yung(6), Joy Gumin(6), B. Nebiyou Bekele(6), Timothy J. McDonnell(5), Raymond Sawaya(5), W.K. Alfred Yung(5), W.K. Alfred Yung(5), Vanesa Martı́n(5), Jing Xu(5), Gregory N. Fuller(4), David T. Curiel(4)